基础研究
Copyright ©The Author(s) 2014.
世界华人消化杂志. 2014-11-08; 22(31): 4726-4733
在线出版 2014-11-08. doi: 10.11569/wcjd.v22.i31.4726
表1 A组第14天、第21天CT灌注参数比较
分组时间(d)BF[mL/(min100 g)]BV(mL/100 g)MTT(s)PS[mL/(min100 g)]HAF(100%)
TR1466.01±13.1621.09±5.4919.59±4.3868.05±13.000.46±0.25
2179.97±22.85a25.74±6.2014.98±3.64b78.10±11.38a0.60±0.17
NR1445.49±8.05b12.27±2.16b39.03±6.23b51.02±16.94b0.16±0.20a
2152.01±8.74d12.63±1.48d37.59±4.05d37.78±11.81d0.32±0.13d
表2 不同单能量成像下的能谱曲线的斜率比较
分组K50K60K70K80K90K100K110K120K130K140
AP
TR9.80±0.927.89±0.736.48±0.605.45±0.514.67±0.434.07±0.383.60±0.343.22±0.302.91±0.272.65±0.25
NR4.31±1.953.47±1.572.84±1.292.39±1.082.05±0.931.79±0.811.58±0.721.42±0.641.28±0.581.17±0.53
t6.246.286.266.256.236.246.246.246.236.26
P0.000.000.000.000.000.000.000.000.000.00
PVP
TR10.44±0.988.54±0.847.00±0.645.92±0.545.05±0.464.41±0.403.90±0.353.48±0.323.15±0.292.87±0.26
NR9.64±1.437.85±0.946.51±0.785.48±0.654.70±0.574.11±0.503.63±0.453.25±0.402.93±0.362.67±0.33
t2.142.502.262.362.152.132.122.112.112.10
P0.040.020.030.020.040.040.040.040.040.04
表3 A组TR、NR标准化碘含量随时间变化情况 (mg/mL)
分组A组
B组
第14天第21天第21天
AP
TR0.61±0.070.73±0.150.55±0.30
NR0.42±0.030.60±0.130.37±0.18
t3.752.354.98
P0.020.030.04
PVP
TR0.52±0.230.58±0.100.53±0.26
NR0.55±0.580.60±0.920.50±0.02
t0.310.420.18
P0.590.680.68
表4 抗血管生成治疗前后肿瘤边缘区CT灌注参数值比较 (n = 30)
分组BF[mL/(min100 g)]BV(mL/100 g)MTT(s)PS[mL/(min100 g)]HAF(100%)
A组(第21天)79.97±22.8525.74±6.2014.98±3.6478.10±11.380.60±0.17
B组(第21天)67.77±25.0720.81±8.0720.63±8.4064.84±17.520.30±0.24
t8.682.24-3.412.774.75
P0.010.040.000.010.00
表5 A、B两组CT灌注参数、NIC与VEGF、FGF2相关性分析
分组BF
BV
MTT
PS
HAF
NIC during AP
rPrPrPrPrPrP
FGF2
A组0.990.000.990.000.630.040.550.050.980.000.990.00
0.740.000.870.000.530.030.780.010.700.040.810.01
B组0.930.000.790.000.680.050.720.000.630.020.990.00
VEGF
A组0.940.000.930.000.730.040.900.000.950.000.640.03
0.970.000.930.000.820.030.960.000.950.000.930.00
B组0.940.040.990.000.640.020.720.030.650.040.730.03

引文著录: 周悦, 王明月, 高剑波, 董军强, 许瀚, 侯平. 宝石CT能谱成像及灌注成像评价兔VX2肝癌抗血管生成的治疗疗效. 世界华人消化杂志 2014; 22(31): 4726-4733